Kerala Ayurveda Ltd.
Snapshot View

View in App

Prices View details >>

106.90 +5.05 ▲5.0%

02 February 2023, 04:01:00 PM
Volume: 3,978

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.keralaayurveda.biz
Market Cap 112.58 Cr.
Enterprise Value(EV) 178.04 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 2.63 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 40.63 Trailing Twelve Months Ending 2022-09
Industry PE 32.44 Trailing Twelve Months Ending 2022-09
Book Value / Share 3.12 Trailing Twelve Months Ending 2022-09
Price to Book Value 34.28 Calculated using Price: 106.90
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.06 Cr. 10,555,670 Shares
FaceValue 10
Company Profile
Kerala Ayurveda Ltd. (KAL) was founded on the banks of river Periyar at Aluva, Kochi, Kerala in 1945 by Late Vaidyan K G K Panicker, the renowned Ayurvedacharya. He was a doyen in Ayurvedic system, a visionary and a mentor. Now, more than half a century later, his inspired creation epitomizes all that is modern and state-of-the-art in Ayurveda. A leading Ayurvedic company today, KAL is backed by advanced technology and highly qualified dedicated staff.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+4.96%
1 Week
-0.19%
1 Month
-3.04%
3 Month
+33.62%
6 Month
+39.01%
1 Year
+47.45%
2 Year
+115.96%
5 Year
+15.69%
10 Year
+178.02%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 862.54 38.72 43.39 93.90 -183.03 137.66
Return on Capital Employed (%) 5.38 8.35 9.15 8.91 8.88 7.64 9.27 -0.45 12.62
Return on Assets (%) 1.47 3.72 3.81 4.27 3.14 2.59 4.15 -4.47 2.14

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds -10 -9 -6 7 8 4 8 3 6 6
Non Curr. Liab. 51 53 53 24 48 59 63 67 42 46
Curr. Liab. 23 25 24 48 45 28 31 42 60 60
Minority Int. 1 1 1 1 2 2 2 2 2 2
Equity & Liab. 64 71 73 81 103 92 103 114 110 114
Non Curr. Assets 55 57 59 59 61 64 67 67 70 74
Curr. Assets 9 14 14 22 42 28 33 44 37 40
Misc. Exp. not W/O 3 3 3
Total Assets 64 71 73 81 103 92 103 114 110 114

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 35 39 46 50 56 62 77 62 80 83
Other Income 1 0 1 0 0 1 0 0 0 0
Total Income 35 39 46 51 56 63 77 62 81 83
Total Expenditure -32 -33 -39 -43 -48 -57 -69 -61 -71 -73
PBIDT 4 6 8 7 8 5 7 1 10 10
Interest -1 -2 -2 -1 -2 -3 -2 -6 -7 -5
Depreciation -1 -1 -2 -2 -2 -1 -1 -1 -1 -1
Taxation -1 -1 -1 -1 -1 -1 0 2 0 -1
Exceptional Items 0 1 1 0
PAT 1 3 3 3 3 3 4 -5 2 3
Minority Interest 0 0 0 0 0 0 0 0 0
Share Associate
Other Related Items
Consolidated Net Profit 1 2 3 3 3 2 4 -5 2 3
Adjusted EPS 1 2 3 3 3 2 4 -5 2 3

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -8 0 0 6 4 -10 12 5 7 -1
Cash Fr. Inv. -4 -1 0 -3 -3 -3 -3 -4 -1 -2
Cash Fr. Finan. 11 1 2 -3 0 17 -12 1 6 -13
Net Change 0 -1 2 0 1 4 -2 2 12 -16
Cash & Cash Eqvt 1 1 2 2 3 7 5 6 19 3

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 61.52 61.52 61.52 61.52 61.52 61.52 61.52 61.52 61.52
Public 38.48 38.48 38.48 38.48 38.48 38.48 38.48 38.48 38.48
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 100.00 100.00 100.00 100.00 100.00 100.00 100.00 0.00 100.00

Announcements View Details >>

Wed, 04 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Compliance- certificate under Reg.74(5) of SEBI(LODR) Regulations 2018
Fri, 30 Dec 2022
Closure of Trading Window
Trading window will be closed from 31st December 2022 Till the announcement of the Financial Results for the quarter ended on that date.
Wed, 14 Dec 2022
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Kerala Ayurveda Limited Charters a New Beginning after 80+ Years of Unparalleled Ayurvedic practice: A New Era A New Beginning

Technical Scans View Details >>

Thu, 02 Feb 2023
High Delivery Percentage High Delivery Percentage
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
Opening at Low Opening at Low
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase in 3 Months High Increase in 3 Months

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 241,852.96 1,008.00 -0.6%
Divi's Laboratories Ltd. 86,732.57 3,271.90 -2.5%
Cipla Ltd. 82,728.22 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. 72,771.66 4,366.00 +0.4%
Apollo Hospitals Enterprise Ltd. 60,864.05 4,234.95 -0.8%
Torrent Pharmaceuticals Ltd. 52,144.29 1,541.15 +0.5%
Zydus Lifesciences Ltd. 43,787.95 432.60 -0.7%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 57.42 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-09 29.03 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-12 31.36 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.95 4,366.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.52 4,234.95 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.77 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-09 22.59 432.60 -0.7%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.37 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-09 7.16 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-12 3.65 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.30 4,366.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.17 4,234.95 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.18 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-09 2.63 432.60 -0.7%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-03 0.04 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,366.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,234.95 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 432.60 -0.7%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,366.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,234.95 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 432.60 -0.7%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,366.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,234.95 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 432.60 -0.7%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,366.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,234.95 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 432.60 -0.7%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,366.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,234.95 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 432.60 -0.7%

FAQ's On Kerala Ayurveda Ltd.

What is Kerala Ayurveda share price?
Can I buy Kerala Ayurveda shares now?
What is the Market Cap of Kerala Ayurveda?
What are the key metrics to analyse Kerala Ayurveda?
What is the 52 Week High and Low of Kerala Ayurveda?
What is the trend of Kerala Ayurveda share price?